Navigation Links
Study finds most adolescents sent to group homes still involved with drugs/crime seven years later
Date:3/19/2009

Most adolescents referred to long-term group homes in Los Angeles County after being charged with a serious offense reported they were still involved with crime or drugs seven years later, according to a new RAND Corporation study.

The bleak findings suggest there is a need to improve juvenile justice rehabilitation programs, according to the report published online by the American Journal of Public Health.

Studies rarely track juvenile offenders for so long so that little is known about the prognosis for juvenile offenders nationally. However, the youths in this study were similar to the national profile of youths in juvenile correctional facilities and a similar study conducted in Chicago found similar mortality rates.

Researchers studied 449 adolescents aged 13 to 17 who were referred to group homes by judges in Los Angeles County between February 1999 and May 2000. The participants were interviewed periodically over the next seven years to assess how their lives had progressed.

When attempts were made to re-contact these young people in 2007, researchers learned that 12 of the young people had died, including seven from gunshot wounds. Among the 383 participants who completed the final interview, 36 percent had used hard drugs in the past year and 27 percent reported five or more symptoms of substance dependence.

Among the group that completed the final interview, 66 percent reported they had done something illegal, other than using alcohol or drugs, in the previous year. Thirty-seven percent reported being arrested within the previous year and 25 percent had been in jail or prison every day for the previous 90 days.

"We cannot say that these group homes failed to improve anyone's life, but the large number of poor outcomes we observed raises questions about whether the juvenile justice system is as effective in rehabilitating delinquent youths as it should be," said Rajeev Ramchand, the study's
'/>"/>

Contact: Warren Robak
robak@rand.org
310-451-6913
RAND Corporation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study Finds Millions More May Benefit From Statins
2. Gleevec Prevents Return of Intestinal Cancer, Study Confirms
3. New Clinical Study News for Treatment of Sinusitis - Sinus Infection and Allergy Suffers Now Have a New Effective Form of Relief through Sinus Dynamics
4. Study finds extensive patient sharing among hospitals; could impact spread of infectious diseases
5. Northern California Cancer Center Study Seeks to Improve Colon Cancer Screening in Vietnamese Communities
6. Study finds how brain remembers single events
7. MHA to Release Results of Second Annual Independent Long Term Care Member Study
8. Spinal taps carry higher risks for infants and elderly, study shows
9. Study finds biological clue in brain tumor development
10. Researcher wins $2.6 million grant for depression care study
11. Study gives more proof that intelligence is largely inherited
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 2Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 3Health News:First Boston Pharma, LLC Acquires NutraMax Products, Inc. 2Health News:Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform 2Health News:BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock 2Health News:BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock 3Health News:BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock 4Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2Health News:'Super Lice' Repelled by All-Natural Products First Ever Independent Study Shows 2
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 1The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 2New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 1New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 2Testosterone Therapy May Help Men With Heart Failure 55194 1Testosterone Therapy May Help Men With Heart Failure 55194 2Testosterone Therapy May Help Men With Heart Failure 55194 3